Vyvanse 60mg

Description

Vyvanse 60mg is a prescription medicine mainly used for treating Attention Deficit Hyperactivity Disorder in adults and children and is approved to treat binge eating disorder of moderate to severe degree in adults. Vyvanse helps boost attention and lessens impulsiveness and hyperactivity in patients with ADHD. Being a central nervous system stimulant itself, it becomes very instrumental in symptom management, thereby improving the quality of life in patients.

Active Ingredient and Classification 

 It falls under the category of central nervous system stimulants. Lisdexamfetamine becomes a prodrug for the delivery of dextroamphetamine; it gets converted into dextroamphetamine inside the body. This classification explains it all—its action on those brain chemicals and nerves that contribute to hyperactivity and impulse control.

Indications and Uses

Vyvanse 60mg is indicated for the treatment in adults and children aged 6 years and older. It is also indicated for the treatment of moderate to severe binge eating disorder in adults. For attention deficit hyperactivity disorder, the medicine targets symptoms of the disorder to improve focus, attention, and behavior. BED facilitates a reduction in the number of days of binge eating and thus helps subjects gain better control over their intake of food.

Dosage and Administration

The recommended starting dose for ADHD is 30mg once daily in the morning; dosages may be increased in increments of 10mg or 20mg per week to a maximum of 70mg per day. BED patients have an initial dosage of 30mg once daily, with similar titration. Vyvanse should be taken in the morning to avoid insomnia and should be swallowed whole or opened and mixed with water, yogurt, or orange juice. It is worth noting that prescription medication should always be taken per dose, by form, and by method of administration to derive desired effects and minimize adverse effects.

Mechanism of Action

Vyvanse works by affecting neurotransmitters in the brain. Lisdexamfetamine, being a prodrug, undergoes hydrolysis to dextroamphetamine – its active pharmaceutical intermediate. This increases the concentration of dopamine and norepinephrine, leading to increased focus, attention, and impulse control in ADHD and decreasing the urge for food in binge eating disorder. Its gradual hydrolysis into the active metabolite provides a prolonged therapeutic effect with minimal possibility of abuse.

Adverse Effects 

Common side effects of Vyvanse include dry mouth, loss of appetite, weight loss, insomnia, and an increased heart rate. Serious side effects, though rare, might include severe allergic reactions, heart problems, and mental health issues like new or exacerbating bipolar disorder or psychosis. The patient should report unusual symptoms or side effects to the healthcare provider immediately for proper management and adjustment of treatment.

Warnings and Precautions

Vyvanse should be given carefully to patients with a history of heart illnesses, arterial hypertension, or psychic disorders. It is not recommended for pregnant and lactating women, except in cases of necessity, upon the discretion of a doctor. Additionally, patients must avoid ethanol and be careful about possible drug interactions, especially with MAO inhibitors that might have serious and fatal interactions. Continuous monitoring by the doctor is an essential factor in managing risks.

Storage Instructions

Vyvanse should be stored at room temperature: 68°F to 77°F (20°C to 25°C) in a tightly closed container, protecting it from light and moisture. Keep the medication out of reach of children and pets. Do not store Vyvanse in the bathroom or near any sources of heat. Proper storage will help to keep the medication effective and safe. Dispose of unused or expired medication according to local regulations or pharmacy guidelines so it doesn’t get into the wrong hands or perhaps be taken by accident.